Bottom line
PHSYX vs PRHSX: the short answer
PHSYX (Putnam Global Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 62% by weight.
But PRHSX is far broader, holding 279 positions to 115 for PHSYX, so beyond the top names it adds exposure PHSYX doesn't have.
PHSYX is cheaper at 0.79% vs 0.83% — a difference of $4.00 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +4.2% for PRHSX (reporting dates differ).
Updated Nov 19, 2026
PHSYX vs PRHSX side by side
| PHSYX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.79% | 0.83% |
| Annual cost per $10k | $79 | $83 |
| 10-yr cost on $10k (prospectus) | $978 | $1,025 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | — |
| 1-yr return | +1.5% | +17.7% |
| 5-yr return (annualized) | +8.1% | +4.2% |
| 10-yr return (annualized) | +7.8% | +9.1% |
| Best quarter | — | +23.5% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $1.5B | $11.9B |
| Number of holdings | 115 | 279 |
| Portfolio turnover | 67% | 62% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of PHSYX's top 25 holdings also appear in PRHSX's top 25.
| Holding | PHSYX | PRHSX |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 14.28% |
| Johnson & Johnson | 8.46% | 6.63% |
| UnitedHealth Group, Inc. | 6.93% | 5.99% |
| AbbVie, Inc. | 6.05% | 5.10% |
| Merck & Co., Inc. | 4.88% | 4.01% |
| Thermo Fisher Scientific, Inc. | 4.50% | 2.52% |
| Intuitive Surgical, Inc. | 4.04% | 1.87% |
| CVS Health Corp. | 2.74% | 0.94% |
| Gilead Sciences, Inc. | 2.63% | 2.82% |
| Cardinal Health, Inc. | 2.12% | 1.03% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.28% |
| Bristol-Myers Squibb Co. | 1.75% | 2.11% |
| Amgen, Inc. | 1.11% | 1.82% |
Source: SEC Form N-PORT
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between PHSYX and PRHSX?
Which is cheaper, PHSYX or PRHSX?
Should I own both PHSYX and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.